Thermo Fisher stock gains as CLSA starts coverage with Outperform rating
Published on 09/04/2026 at 11:30 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Thermo Fisher Scientific (ISIN US8835561023) stock is trading close to recent highs, with the shares at around USD 618.40 as of September 4, 2026 after a 1.63% advance from a previous close of USD 608.54 according to market data compiled by MEXC.
Fresh analyst call supports valuation
A new analyst initiation adds a clear catalyst for Thermo Fisher stock. According to a research call summary compiled by 247WallSt, CLSA has initiated coverage of Thermo Fisher Scientific with an Outperform rating and a target price of USD 748 per share.
The implied upside from the CLSA target is substantial. Based on the recent price level of about USD 618 as of September 4, 2026, the USD 748 target suggests that analysts at CLSA see room for Thermo Fisher stock to rise by roughly 21% if their scenario plays out.
Quarterly figures and guidance underpin bullish view
Behind the positive analyst stance is a set of robust fundamentals. As summarized by an earnings overview on MarketBeat, Thermo Fisher Scientific most recently reported quarterly earnings per share of USD 6.03, beating a consensus estimate of USD 5.71 by USD 0.32 for the latest reported quarter.
In the same quarter, Thermo Fisher generated revenue of USD 11.99 billion compared with analyst expectations of USD 11.71 billion, meaning revenue exceeded the Street view by USD 0.28 billion and was up 10.5% compared with the same quarter a year earlier according to the same MarketBeat summary.
The earnings quality appears solid as well. MarketBeat reports that Thermo Fisher delivered a return on equity of 17.09% and achieved a net margin of 15.04% in the latest reported quarter, metrics that help explain why analysts are comfortable forecasting full year earnings per share of around USD 25.13 for fiscal 2026.
Management guidance provides an additional anchor. According to the MarketBeat data, Thermo Fisher has set its fiscal year 2026 earnings guidance in a range of USD 24.93 to USD 25.33 per share, and the current analyst consensus of roughly USD 25.13 sits within this band, indicating alignment between internal expectations and external forecasts.
Thermo Fisher Scientific stock and fundamentals at a glance
Investors can explore more headlines and filings linked to Thermo Fisher Scientific stock and its latest financials and guidance with one click.
Stock trades near recent high after two days of gains
The positive fundamental picture has translated into a resilient share price. According to a recent price report on MarketWatch, Thermo Fisher Scientific shares rallied 1.63% to USD 618.43 on September 3, 2026, outperforming the broader S&P 500, which rose 1.06% on the same trading day.
This was the second consecutive day of gains for the stock, suggesting investors are steadily rewarding the company for its earnings beat and guidance while also responding to fresh analyst coverage. With the latest price of roughly USD 618.40 reported by MEXC as of early trading on September 4, 2026, Thermo Fisher stock remains close to that MarketWatch closing level.
From a valuation perspective, the MarketBeat overview notes that Thermo Fisher opened at around USD 608.33 in the latest session referenced there, so the move toward the USD 618 area represents a gain of more than USD 10 from that opening reference point as investors absorb the recent flow of news.
Life science tools remain a core growth driver
Beyond stock market metrics, Thermo Fisher Scientific remains deeply embedded in the laboratory and clinical workflows that underpin modern science. A recent application article on News Medical highlights the NanoDrop Ultra spectrophotometer as a tool that simplifies calculations for downstream RT qPCR and qPCR reactions, illustrating the practical role Thermo Fisher instruments play in everyday molecular biology.
For investors, such references underscore how Thermo Fisher products are tied to recurring workflows, often generating repeat demand for instruments, consumables and reagents. This recurring nature of laboratory needs helps explain why revenue in the latest reported quarter rose by 10.5% compared with the prior year according to the MarketBeat earnings summary, and why analysts expect full year earnings per share to remain firmly above USD 24 in fiscal 2026.
Closing look at Thermo Fisher stock
Thermo Fisher stock was quoted at about USD 618.40 as of September 4, 2026, based on MEXC trade data for the TMO common stock line, representing an intraday gain of 1.63% versus the previous close of USD 608.54 and keeping the shares near their recent closing high of USD 618.43 reported by MarketWatch for September 3, 2026.
Thermo Fisher Scientific stock facts
- Company: Thermo Fisher Scientific Inc.
- ISIN: US8835561023
- Ticker: TMO
- Trading venue: NYSE
- Price (as of September 4, 2026, 00:01): 618.40 USD
- Market capitalization: 94,000,000,000 USD (as of September 4, 2026, based on recent price and typical share count)
- Sector / Industry: Health Care / Life Sciences Tools and Services
- Index membership: S&P 500
